Total Payments
$3,492
2024 Payments
$1,355
Companies
24
Transactions
190
Medicare Patients
4,222
Medicare Billing
$329,775
Payment Breakdown by Category
Food & Beverage$3,480 (99.7%)
Education$11.71 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,480 | 189 | 99.7% |
| Education | $11.71 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $491.95 | 31 | $0 (2024) |
| Novo Nordisk Inc | $439.94 | 24 | $0 (2024) |
| Lilly USA, LLC | $432.44 | 26 | $0 (2024) |
| Amgen Inc. | $376.02 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $334.88 | 17 | $0 (2024) |
| PFIZER INC. | $264.42 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $160.48 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $144.47 | 8 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $108.55 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $96.56 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,355 | 69 | Lilly USA, LLC ($179.73) |
| 2023 | $1,649 | 93 | AbbVie Inc. ($294.62) |
| 2022 | $458.19 | 26 | Biohaven Pharmaceutical Holding Company Ltd. ($92.55) |
| 2018 | $11.12 | 1 | Amgen Inc. ($11.12) |
| 2017 | $18.17 | 1 | Amgen Inc. ($18.17) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: Bone Health | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Gastroenterology | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: Biological | ||||||
| 08/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: UROLOGY | ||||||
| 08/22/2024 | Philips North America LLC | (CK6) Holter (Device) | Food and Beverage | Cash or cash equivalent | $20.98 | General |
| Category: Medical Device | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Obesity | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.64 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: VACCINES | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 435 | 541 | $68,633 | $41,409 |
| 2022 | 16 | 662 | 759 | $132,048 | $44,790 |
| 2021 | 22 | 1,588 | 3,070 | $365,286 | $130,154 |
| 2020 | 21 | 1,537 | 2,777 | $285,348 | $113,422 |
Total Patients
4,222
Total Services
7,147
Medicare Billing
$329,775
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 123 | $21,472 | $11,765 | 54.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 106 | $12,554 | $7,328 | 58.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $7,748 | $5,555 | 71.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 23 | 23 | $6,411 | $3,982 | 62.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $7,764 | $3,554 | 45.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $3,245 | $3,097 | 95.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 34 | $3,060 | $2,370 | 77.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 14 | 20 | $1,600 | $1,149 | 71.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 34 | $1,234 | $1,089 | 88.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 70 | 76 | $2,323 | $894.25 | 38.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $323.00 | $301.50 | 93.3% |
| 90471 | Administration of vaccine | Office | 2023 | 19 | 20 | $819.80 | $290.70 | 35.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 12 | 13 | $80.03 | $32.83 | 41.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 113 | 113 | $30,322 | $15,784 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 204 | $50,969 | $9,604 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 140 | $24,715 | $4,282 | 17.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 22 | 22 | $6,544 | $3,921 | 59.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $7,325 | $3,365 | 45.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $3,540 | $3,337 | 94.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 18 | $1,620 | $1,234 | 76.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 23 | 23 | $630.00 | $623.70 | 99.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 14 | 18 | $1,440 | $545.76 | 37.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 21 | $600.00 | $538.32 | 89.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 47 | $1,562 | $518.29 | 33.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 20 | 40 | $1,174 | $386.43 | 32.9% |
About Dr. Eric Carr, M.D
Dr. Eric Carr, M.D is a Internal Medicine healthcare provider based in Owings Mills, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093737447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Carr, M.D has received a total of $3,492 in payments from pharmaceutical and medical device companies, with $1,355 received in 2024. These payments were reported across 190 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,480).
As a Medicare-enrolled provider, Carr has provided services to 4,222 Medicare beneficiaries, totaling 7,147 services with total Medicare billing of $329,775. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Owings Mills, MD
- Active Since 07/24/2006
- Last Updated 04/11/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093737447
Products in Payments
- NURTEC ODT (Drug) $210.26
- QULIPTA (Drug) $206.89
- Wegovy (Drug) $185.04
- TRELEGY ELLIPTA (Drug) $183.26
- EVENITY (Biological) $179.44
- UBRELVY (Drug) $163.52
- Otezla (Drug) $150.69
- Rybelsus (Drug) $141.29
- TRULICITY (Drug) $138.91
- SHINGRIX (Biological) $123.84
- MOUNJARO (Drug) $122.75
- LEQVIO (Drug) $113.57
- GEMTESA (Drug) $108.55
- TRINTELLIX (Drug) $96.56
- INJECTAFER (Drug) $94.46
- ELIQUIS (Drug) $82.10
- VRAYLAR (Drug) $82.09
- JARDIANCE (Drug) $80.70
- EMGALITY (Drug) $78.37
- NEXLETOL (Drug) $77.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Owings Mills
Dr. Sean Holmes, M.d, M.D
Internal Medicine — Payments: $22,049
Internal Medicine $22,049
Dr. Pankaj Desai, M.d., Facp, M.D., FACP
Internal Medicine — Payments: $22,032
Internal Medicine $22,032
Elliot Rothschild, Md, MD
Internal Medicine — Payments: $14,109
Internal Medicine $14,109
Dr. Thomas Withuhn, M.d., M.s, M.D., M.S
Internal Medicine — Payments: $12,000
Internal Medicine $12,000
Tamara Sobel, M.d, M.D
Internal Medicine — Payments: $5,658
Internal Medicine $5,658
Ellie Goldbloom, M.d, M.D
Internal Medicine — Payments: $5,352
Internal Medicine $5,352